Coloplast A/S banner

Coloplast A/S
OTC:CLPBY

Watchlist Manager
Coloplast A/S Logo
Coloplast A/S
OTC:CLPBY
Watchlist
Price: 7.76 USD
Market Cap: $17.5B

Net Margin

14.3%
Current
Declining
by 3.3%
vs 3-y average of 17.6%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
14.3%
=
Net Income
kr4B
/
Revenue
kr27.9B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
14.3%
=
Net Income
$4B
/
Revenue
kr27.9B

Peer Comparison

Country Company Market Cap Net
Margin
DK
Coloplast A/S
CSE:COLO B
110.7B DKK
Loading...
JP
Hoya Corp
TSE:7741
9.6T JPY
Loading...
US
Medline Inc
NASDAQ:MDLN
59.5B USD
Loading...
CH
Alcon AG
SIX:ALC
30.3B CHF
Loading...
US
Align Technology Inc
NASDAQ:ALGN
14.2B USD
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.6B GBP
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
41.5B CNY
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.1B CHF
Loading...
US
Merit Medical Systems Inc
NASDAQ:MMSI
4.8B USD
Loading...
KR
HLB Inc
KOSDAQ:028300
6.9T KRW
Loading...

Market Distribution

In line with most companies in Denmark
Percentile
68th
Based on 559 companies
68th percentile
14.3%
Low
-18 280.1% — 1.4%
Typical Range
1.4% — 15.8%
High
15.8% — 2 389.6%
Distribution Statistics
Denmark
Min -18 280.1%
30th Percentile 1.4%
Median 3.9%
70th Percentile 15.8%
Max 2 389.6%

Coloplast A/S
Glance View

Coloplast A/S, headquartered in Humlebæk, Denmark, has a storied history that dates back to 1954 when a nurse, Elise Sørensen, identified a crucial need in the healthcare sector. Her sister had undergone ostomy surgery, and the lack of appropriate post-operative care products inspired Sørensen to design the world’s first adhesive ostomy bag. This innovation laid the groundwork for Coloplast's trajectory in the healthcare industry. Today, the company has expanded its focus to include ostomy care, continence care, wound and skin care, and interventional urology. With a commitment to improving patients' quality of life, Coloplast has become a leader in designing and manufacturing products that not only highlight practicality but also embody comfort and discretion. Coloplast generates revenue through a business model that emphasizes product innovation and direct engagement with healthcare providers and patients. The company invests significantly in research and development to improve and widen its product offerings continuously. It operates globally, distributing its products directly and via partnerships with hospitals, clinics, and healthcare professionals. By maintaining an attentive approach to user experience and incorporating customer feedback into its development processes, Coloplast ensures its portfolio aligns with the actual needs of its users. This user-centered strategy not only enhances customer loyalty but also fortifies the company’s market position, driving its financial success.

CLPBY Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
14.3%
=
Net Income
kr4B
/
Revenue
kr27.9B
What is Coloplast A/S's current Net Margin?

The current Net Margin for Coloplast A/S is 14.3%, which is below its 3-year median of 17.6%.

How has Net Margin changed over time?

Over the last 3 years, Coloplast A/S’s Net Margin has decreased from 19.7% to 14.3%. During this period, it reached a low of 13% on Sep 30, 2025 and a high of 19.9% on Mar 31, 2023.

Back to Top